CERRANO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.287
EU - Europa 709
AS - Asia 427
SA - Sud America 23
AF - Africa 14
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.480
Nazione #
US - Stati Uniti d'America 1.272
CN - Cina 230
IT - Italia 228
IE - Irlanda 92
SE - Svezia 84
KR - Corea 64
DE - Germania 60
FR - Francia 48
VN - Vietnam 34
IN - India 25
AT - Austria 24
UA - Ucraina 24
ES - Italia 23
GB - Regno Unito 23
FI - Finlandia 21
JP - Giappone 21
BR - Brasile 14
CA - Canada 14
TW - Taiwan 13
UZ - Uzbekistan 13
CH - Svizzera 11
PL - Polonia 11
AU - Australia 10
BY - Bielorussia 10
SN - Senegal 10
RU - Federazione Russa 9
NL - Olanda 8
CO - Colombia 7
PT - Portogallo 7
HK - Hong Kong 6
BE - Belgio 5
CZ - Repubblica Ceca 5
SG - Singapore 5
EU - Europa 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
GR - Grecia 3
TR - Turchia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BN - Brunei Darussalam 2
DK - Danimarca 2
ID - Indonesia 2
LT - Lituania 2
LU - Lussemburgo 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
ZA - Sudafrica 2
AR - Argentina 1
BO - Bolivia 1
IR - Iran 1
LI - Liechtenstein 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
Totale 2.480
Città #
Chandler 202
Fairfield 121
Beijing 109
Dublin 91
Ashburn 77
Torino 76
Houston 70
Woodbridge 49
Nyköping 47
Cambridge 46
Redwood City 46
Wilmington 43
Medford 42
Seattle 39
Ann Arbor 37
Dong Ket 27
Princeton 25
Vienna 24
Villeurbanne 24
Jacksonville 23
Dearborn 17
Turin 16
Fremont 15
Seoul 15
Hangzhou 14
Pisa 12
San Diego 11
Milan 9
Nanjing 9
New York 9
Paris 9
Shanghai 9
São Paulo 9
Taipei 9
Hefei 8
Helsinki 8
Warsaw 8
San Mateo 6
Xian 6
Bogotá 5
Brussels 5
Mountain View 5
Norwalk 5
Ottawa 5
Amsterdam 4
Bayreuth 4
Chengdu 4
Hebei 4
Surbo 4
Tokyo 4
Tong 4
Toronto 4
Upper Marlboro 4
Valencia 4
Villanova 4
Wuhan 4
Zhengzhou 4
Accord 3
Augusta 3
Basel 3
Bengaluru 3
Boston 3
Brno 3
Budapest 3
Central District 3
Chennai 3
Chicago 3
Duncan 3
Freudenstadt 3
Guangzhou 3
Hyderabad 3
Kunming 3
Linda-a-velha 3
Lissone 3
Munich 3
Nanchang 3
Northampton 3
Palermo 3
Phoenix 3
Radomsko 3
Rochester 3
Sant Cugat Del Vallès 3
Singapore 3
Absecon 2
Bologna 2
Campinas 2
Collegeville 2
Düsseldorf 2
Edinburgh 2
Faenza 2
Felgueiras 2
Florence 2
Guiyang 2
Hanoi 2
Istanbul 2
Johannesburg 2
Luxembourg 2
Madrid 2
Mortara 2
Málaga 2
Totale 1.606
Nome #
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives 275
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 245
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 186
FLAI induction regimen in elderly patients with acute myeloid leukemia 171
Can pegylated interferon improve the outcome of polycythemia vera patients? 168
Anemia in the Elderly: not Always what it Seems. 141
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice 131
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice 118
THE COMBINATION OF FLUDARABINE + CITARABINE + IDARUBICIN (FLAI) IS A SAFE AND EFFECTIVE TREATMENT FOR ELDERLY PATIENTS WITH AML OR HIGH RISK MDS 116
TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS 94
IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE 86
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications 85
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 81
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience 75
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm. 73
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. 71
CHRONIC MYELOID LEUKEMIA WITH EXTREME THROMBOCYTOCIS AT THE DIAGNOSIS: A NEW SUBSET 70
Biomarkers for acute and chronic graft versus host disease: state of the art 66
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 57
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience 55
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation 55
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation 48
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience 47
null 37
Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: Improving patient outcomes with a multidisciplinary approach 23
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study 2
Totale 2.576
Categoria #
all - tutte 6.485
article - articoli 0
book - libri 0
conference - conferenze 1.340
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201977 0 0 0 0 0 0 0 0 0 14 45 18
2019/2020346 9 7 7 29 18 26 30 40 88 44 21 27
2020/2021630 18 56 45 47 40 29 51 64 67 45 80 88
2021/2022495 27 40 29 61 35 25 28 22 16 35 101 76
2022/2023583 54 67 19 62 42 135 38 48 48 15 39 16
2023/2024174 28 43 8 19 16 36 3 13 1 7 0 0
Totale 2.576